According to FutureWise analysis the market for Fecal Occult Testing in 2023 was US$ 1.64 billion, and is expected to reach US$ 2.22 billion by 2031 at a CAGR of 5.7%.
A test for fecal occult blood looks for blood in your poop, or faeces. A small sample of stool is collected and sent to a doctor or laboratory for testing in a special collection tube or on a special card. Blood in the stool could indicate colorectal cancer or other issues like polyps, ulcers, or haemorrhoids. There are two types of faecal occult blood tests: guaiac faecal occult blood test and immunochemical faecal occult blood test. Guaiac faecal occult blood test looks for blood in the stool using a chemical called guaiac. An antibody is used in the immunochemical faecal occult blood test to detect blood in the stool. Also known as FOBT.
Fecal occult testing is currently being encouraged because of the rising awareness of early screening because it allows for quick medical decisions, offers efficient healthcare, improves the quality of life, and lowers mortality rates. One of the significant factors driving the market expansion is the growing emphasis on integrated health services for better patient experiences and health outcomes, which is occurring at the same time as a growing preference for point-of-care diagnostics (POCD). In addition, as the chance of developing diseases rises with aging, the market is growing faster due to the growing geriatric population. As a result, multiple FOBT screening programs for senior citizens are being implemented by regulatory bodies in various nations. Furthermore, the market is expanding as a result of the increased use of minimally invasive (MI) procedures. Alongside this, immunochemical fecal occult blood tests (iFOBTs or FITs) are gaining interest as they are straightforward to use and clinically more sensitive to malignancies and advanced adenomas. During the forecast period, it is estimated that the widespread availability of FOBT devices at online retail stores will positively affect market growth.
Request a Free Sample @ https://www.futurewiseresearch.com/healthcare-market-research/Fecal-Occult-Testing/11640
Fecal Occult Testing Market Segmentation:
By Product
- Guaiac FOB Stool Test
- Immuno-FOB Agglutination Test
- Lateral Flow Immuno-FOB Test
- Immuno-FOB ELISA Test
By End User
- Hospitals
- Clinical Diagnostic Laboratories
- Physicians' Office Laboratories
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in the Fecal Occult Testing Market:
- Quidel Corporation
- EIKEN CHEMICAL CO., LTD.
- Epigenomics AG
- Beckman Coulter, Inc.
- Abbott Laboratories
- Biohit Oyj.
- Polymedco CDP, LLC
- Quest Diagnostics Incorporated
- Randox Laboratories Ltd.
- EDP Biotech
Buy now the latest version of this report:
https://www.futurewiseresearch.com/contact.aspx?rpt=11640%20&type=discount
**Objectives of this Study: **
- To provide a comprehensive analysis of the Fecal Occult Testing Market By Product, By End User and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: [email protected]
FutureWise Research
Contact Person: Vinay Thaploo.
Email: [email protected]
Contact Number: Asia: +91 8605575209 | USA: +1 3477094931
Website: www.futurewiseresearch.com
